UNSPSC 51152038: Mivacurium chyloride

This classification denotes a muscle relaxant with the molecular formula C58H80N2O14.2Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 600ZG213C3, chemically known as (r)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride, (e)-4-octenedioate (2:1) but generally known as mivacurium chloride, which bears US NIH Compound Identifier 5281080.

UNSPSC 51152038 Mivacurium chloride is a Commodity code nominally designating a specific pharmaceutical agent, but recent state and local procurement activity under this code shows a significant mismatch: the sole recent opportunity tags naloxone and drug deactivation systems procurement, which are unrelated products. State and local governments do not appear to be actively soliciting mivacurium chloride itself through this code in current contracting cycles. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, through competitive bidding via the county's e-Procurement Portal. The county requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping costs. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period. Bidders must submit unit costs for each line item and comply with drug-free workplace certification, E-Verify requirements, and specific insurance coverage including workers' compensation and professional liability. The procurement is potentially FEMA-funded and subject to federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.